H.A.M. Kooistra

h.a.m.kooistra umcg.nl


  1. CD47 Expression Defines the Efficacy of Rituximab in Non-Germinal Center B-Cell (non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

    Van Meerten, T., Bouwstra, R., He, Y., Janneke, D. B., Kooistra, H., Fehrmann, R., Ammatuna, E., Huls, G. & Bremer, E., 29-Nov-2018, In : Blood. 132, Suppl.1, 3 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinoma

    van der Boom, T., Hesselink, E. N. K., Kooistra, H. A. M., Meijer, K., van der Horst-Schrivers, A. N. A., Lefrandt, J. D. & Links, T. P., 1-Jun-2017, In : Endocrine-Related cancer. 24, 6, p. 267-273 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (16) »

ID: 496331